Neuren Pharmaceuticals | NEU - Ordinary Share Capital

Stock Price
12.24
Daily Change
0.21 1.75%
Monthly
4.79%
Yearly
31.75%
Q2 Forecast
11.77

Neuren Pharmaceuticals reported AUD126.64M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
Clinuvel Pharmaceuticals AUD 50.2M 77.11K Dec/2025
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Genetic Signatures AUD 227.14M 0 Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Medical Developments International AUD 112.66M 2.35M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Organon & Co USD 259.98M 18K Sep/2025
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025